Is topical haloperidol a useful glaucoma treatment?

Area of Science:

• Ophthalmology
• Pharmacology

Background:

• Dopamine receptor antagonists are known to reduce intraocular pressure (IOP) in animal models.
• Glaucoma is a leading cause of irreversible blindness worldwide, characterized by elevated IOP.

Purpose of the Study:

• To evaluate the effect of topical haloperidol, a dopamine receptor blocking drug, on intraocular pressure in healthy human volunteers.
• To determine the potential clinical utility of topical haloperidol in managing intraocular pressure.

Main Methods:

• A randomized, double-blind, single-dose study was conducted.
• Twenty healthy volunteers received topical haloperidol.
• Intraocular pressure was monitored over a six-hour period post-administration.

Main Results:

• A modest reduction in intraocular pressure was observed following topical haloperidol administration.
• The observed reduction in intraocular pressure was not statistically significant (p < 0.05).

Conclusions:

• Topical haloperidol demonstrated a non-significant effect on intraocular pressure in healthy volunteers.
• Based on these findings, topical haloperidol is unlikely to be clinically effective for glaucoma treatment.